Biomarker Imuno-oncology.jpg

Meet with Cambridge Biomedical at Biomarker IO

If you plan to attend the 2018 Biomarkers and Immuno-Oncology World Congress meeting in Boston June 11-13 stop by booth #20 and meet with Cambridge Biomedical's subject matter experts.

Cambridge Biomedical offer established expertise in assay development, assay validation, and sample analysis for biomarkers and Immuno assays. We support simple to highly complex assays for both routine and esoteric use, across a wide range of technologies. We also accommodate study sizes with low, medium, or high volume sample testing requirements.

To arrange specific appointments contact Eric Wexler, Cambridge Biomedical's Director of Business Development at